These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 17981914

  • 41. [Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].
    Li RC, Fang HH, Li YP, Liu YP, Nong Y, Huang GB.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):548-51. PubMed ID: 19040034
    [Abstract] [Full Text] [Related]

  • 42. Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis.
    Toubi E, Kessel A, Slobodin G, Boulman N, Pavlotzky E, Zisman D, Rozenbaum M, Rosner I.
    Ann Rheum Dis; 2007 Jun; 66(6):818-20. PubMed ID: 17148544
    [Abstract] [Full Text] [Related]

  • 43. Immune response after influenza vaccination in children with cancer.
    Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T.
    Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
    [Abstract] [Full Text] [Related]

  • 44. [Safety of an influenza-split-vaccine in children].
    Schmitt-Grohé S, Banzhoff A, Klaassen B, Zielen S.
    Klin Padiatr; 2001 Nov; 213(6):338-42. PubMed ID: 11713714
    [Abstract] [Full Text] [Related]

  • 45. [Vaccination against influenza in patients with rheumatoid arthritis: clinical and antibody response].
    Francioni C, Rosi P, Fioravanti A, Megale F, Pipitone N, Marcolongo R.
    Recenti Prog Med; 1996 Apr; 87(4):145-9. PubMed ID: 8643873
    [Abstract] [Full Text] [Related]

  • 46. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.
    Park JK, Lee YJ, Shin K, Ha YJ, Lee EY, Song YW, Choi Y, Winthrop KL, Lee EB.
    Ann Rheum Dis; 2018 Jun; 77(6):898-904. PubMed ID: 29572291
    [Abstract] [Full Text] [Related]

  • 47. Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment.
    Higashida J, Wun T, Schmidt S, Naguwa SM, Tuscano JM.
    J Rheumatol; 2005 Nov; 32(11):2109-15. PubMed ID: 16265687
    [Abstract] [Full Text] [Related]

  • 48. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
    Levine M, Beattie BL, McLean DM.
    CMAJ; 1987 Oct 15; 137(8):722-6. PubMed ID: 3651943
    [Abstract] [Full Text] [Related]

  • 49. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N, Engelmann H, Kuenzel W, Neumeier E, Saenger R.
    Virus Res; 2004 Jul 15; 103(1-2):163-71. PubMed ID: 15163505
    [Abstract] [Full Text] [Related]

  • 50. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity.
    Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R, Teufel A.
    J Rheumatol; 1994 Jul 15; 21(7):1203-6. PubMed ID: 7966058
    [Abstract] [Full Text] [Related]

  • 51. Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis.
    Ribeiro AC, Laurindo IM, Guedes LK, Saad CG, Moraes JC, Silva CA, Bonfa E.
    Arthritis Care Res (Hoboken); 2013 Mar 15; 65(3):476-80. PubMed ID: 22949223
    [Abstract] [Full Text] [Related]

  • 52. Immune response to influenza vaccine in adult liver transplant recipients.
    Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ.
    Liver Transpl; 2001 Apr 15; 7(4):311-3. PubMed ID: 11303290
    [Abstract] [Full Text] [Related]

  • 53. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
    Elkayam O.
    Clin Dev Immunol; 2006 Apr 15; 13(2-4):349-51. PubMed ID: 17162376
    [Abstract] [Full Text] [Related]

  • 54. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y.
    Vaccine; 2009 Jan 14; 27(3):454-9. PubMed ID: 19022318
    [Abstract] [Full Text] [Related]

  • 55. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R, Ikonen N, Santanen R, Haanpää M, Visakorpi R, Jäppinen P, Valle M.
    J Med Virol; 2001 Nov 14; 65(3):584-9. PubMed ID: 11596097
    [Abstract] [Full Text] [Related]

  • 56. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL.
    Pediatr Infect Dis J; 2007 Feb 14; 26(2):107-15. PubMed ID: 17259871
    [Abstract] [Full Text] [Related]

  • 57. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L, Rudnicka H.
    Przegl Epidemiol; 1993 Feb 14; 47(3):275-83. PubMed ID: 8234846
    [Abstract] [Full Text] [Related]

  • 58. Effective immunization against influenza in pediatric renal transplant recipients.
    Edvardsson VO, Flynn JT, Deforest A, Kaiser BA, Schulman SL, Bradley A, Palmer J, Polinsky MS, Baluarte HJ.
    Clin Transplant; 1996 Dec 14; 10(6 Pt 1):556-60. PubMed ID: 8996778
    [Abstract] [Full Text] [Related]

  • 59. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ, Revicki DA, Szechinski J, Greenwald M, Kivitz A, Barile-Fabris L, Kalsi J, Eames J, Leirisalo-Repo M.
    J Rheumatol; 2008 Jan 14; 35(1):20-30. PubMed ID: 18050385
    [Abstract] [Full Text] [Related]

  • 60. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.
    van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, Kallenberg CG, Bijl M.
    Clin Immunol; 2010 Aug 14; 136(2):228-35. PubMed ID: 20421178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.